QuVa Pharma Completes $275 Million Financing with Syndicate Led by Goldman Sachs Following Multiple Years of Strong Growth, Financing Further Validates 503B Industry Value Proposition, Demonstrates Strength of QuVa Pharma and Attractiveness of Ongoing Business Growth Initiatives News provided by Share this article Share this article SUGAR LAND, Texas, May 6, 2021 /PRNewswire/ -- QuVa Pharma, Inc.("QuVa Pharma"), the leading national 503B outsourcing services company providing hospitals with essential medications in ready-to-administer injectable formats, today announced its latest financing,...